Topic
AI Capex Research
Current research indicates that AI infrastructure demand remains a primary driver for equity market strength, contributing significantly to a 26% year-over-year earnings growth in Q1 2026. This momentum has prompted revisions to market targets, with the S&P 500 projected to reach 8,000, supported by software gains and hardware innovations like Nvidia’s RTX Spark chip. Beyond mega-cap tech, AI-related capital expenditure is fostering a turnaround in small-cap equities and driving renewed M&A activity within the sector. The capital commitment to this space is further highlighted by high-profile moves such as Anthropic’s IPO filing, even as broader markets face headwinds from sticky inflation and headline PCE at 3.8%. Despite these macroeconomic pressures and rising energy costs, institutional flows remain concentrated in US large-cap products that capture AI growth. Ultimately, the research suggests that while inflationary risks persist, the secular trend of AI capex continues to underpin global equity sentiment and valuation expansions.
4307 reports available
All reports
Page 66 of 180
Zealand Pharma 47th Annual Global Healthcare Conference Key Takeaways
Goldman Sachs · Jun 10, 2026
EU Consumer Sector Specialist Commentary
J.P. Morgan · Jun 10, 2026
China Healthcare Hospital Equipment Bidding Update
Goldman Sachs · Jun 10, 2026
The Point For Europe
Citi · Jun 10, 2026
Americas Transportation Valuation Tracker
Goldman Sachs · Jun 10, 2026
Gilead Sciences Inc. (GILD): 47th Annual Global Healthcare Conference Key Takeaways
Goldman Sachs · Jun 10, 2026
Sana Biotechnology Annual Global Healthcare Conference Key Takeaways
Goldman Sachs · Jun 10, 2026
The Point for Asia Pacific
Citi · Jun 10, 2026
Midday Market Intelligence
Goldman Sachs · Jun 10, 2026
Ultragenyx Pharmaceutical Key Takeaways From 47th Annual Global Healthcare Conference
Goldman Sachs · Jun 10, 2026
US Equity Unwind Repeats Friday's Playbook
Citi · Jun 10, 2026
Taiwan GDP Upgrade On Export Surprise
ANZ · Jun 10, 2026
US Strategy Views Supply And Demand
Goldman Sachs · Jun 10, 2026
Ardent Health Inc. Key Takeaways
Goldman Sachs · Jun 10, 2026
The Point For Japan
Citi · Jun 10, 2026
The SMID Point
Citi · Jun 10, 2026
New Amsterdam Pharma 47th Annual Global Healthcare Conference Key Takeaways
Goldman Sachs · Jun 10, 2026
Novo Nordisk Annual Global Healthcare Conference Key Takeaways
Goldman Sachs · Jun 10, 2026
The Need For Speed: Net-Zero Outcomes
HSBC · Jun 10, 2026
Americas Retail Specialty Hardlines Identifying Retailers With Strong Store Overlap With BJs And Costco Amidst Elevated Fuel Costs
Goldman Sachs · Jun 10, 2026
The 720
Goldman Sachs · Jun 10, 2026
Fed Communication And Rates Volatility
Goldman Sachs · Jun 10, 2026
GS Basics CPI Investment Economy Market Derived Inflation
Goldman Sachs · Jun 10, 2026
Europe Equity Research Today's Morning Meeting
J.P. Morgan · Jun 10, 2026